Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study
Sleep Medicine · 2025
DOI: 10.1016/j.sleep.2025.02.037 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Sleep Medicine, 2025. Verfasst von Laure Peter-Derex und 34 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Sleep Medicine and Respiratory Diseases, National Reference Centre for Orphan Diseases, Narcolepsy-Rare Hypersomnias, Croix-Rousse Hospita…. Hauptthemen laut MEDLINE: Narcolepsy, Substance-Related Disorders. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rare Disease Foundation, Rare Diseases Foundation.
Abstract (Originalsprache)
OBJECTIVES: In this multi-center cross-sectional study, we compared substance use patterns (SUPs) between patients with narcolepsy type 1 (NT1) and controls, and investigated, among patients, factors associated with the consumption of the main psychoactive substances. METHODS: Adult patients with NT1 and controls completed questionnaires about tobacco, alcohol, and cannabis use patterns. Unadjusted bivariable then multivariate analyses (adjusted for sex, age, education, family status, and depression) were performed to compare SUPs between controls and patients, and to explore socio-demographic, psycho-behavioral, and clinical determinants of consumptions. RESULTS: We included 235 patients (63.8 % women, 36.4 ± 14.7 years) and 166 controls (69.9 % women, 40.3 ± 14.4 years). Substances co-consumptions were frequent in both groups. Patients with NT1 were more frequently current smokers (32.3 % vs. 20.1 %, p < 0.01) or e-cigarettes users (12.1 % vs 2.4 %, p < 0.001) than controls, while no difference was observed for cannabis use and alcohol misuse. Only the increased likelihood of vaping remained significant in adjusted analysis. Among NT1 patients, smoking was associated with disrupted nighttime sleep (OR[95%CI] = 2.28[1.02-5.12], p < 0.05) and less obesity (OR = 0.24[0.09-0.59], p < 0.05). Alcohol misuse was associated with sleep paralysis (OR = 2.11[1.13-3.91], p < 0.05) and treatments (modafinil: OR = 2.14[1.15-4.01], p < 0.05; sodium oxybate: OR = 0.41[0.17-0.97], p < 0.05). Tobacco and cannabis consumptions were associated with lower physical activity (OR = 0.46 [0.24-0.87], p < 0.05 and OR = 0.25[0.10-0.66], p < 0.01). Alcohol misuse and cannabis use were associated with rule breaking behaviors (OR = 5.89[1.61-21.60], p < 0.05 and OR = 8.52[1.79-40.48], p = 0.01). CONCLUSION: Patients with NT1 do not seem less vulnerable to psychoactive substance use/misuse. Consumptions patterns are associated with multiple dimensions of the disease including sleep-related symptoms, comorbidities, treatments, and psycho-behavioral factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Sleep Medicine and Respiratory Diseases, National Reference Centre for Orphan Diseases, Narcolepsy-Rare Hypersomnias, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon 1 University, Lyon, France; Lyon Neur…
- Transport Work and Environmental Epidemiology Research and Surveillance Unit - UMRESTTE (UMR T9405), University Lyon 1, Lyon, France.
- Lyon Neuroscience Research Centre, INSERM U1028, CNRS UMR 5292, Lyon, France; Swiss Distance Learning University, Faculty of Psychology, Brig, Switzerland.
- Clinical Research Center, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
- National Reference Centre for Orphan Diseases, Narcolepsy-Rare Hypersomnias, Sleep Disorders Clinic, Pitié-Salpêtrière Hospital, APHP-Sorbonne University, Paris, France.
- National Reference Centre for Orphan Diseases, Narcolepsy-Rare Hypersomnias, Sleep Unit, Department of Neurology, CHU Montpellier, Univ Montpellier, Montpellier, France.
Förderung
- Rare Disease Foundation
- Rare Diseases Foundation
Zitieren
APA
Peter-Derex, L., Fort, E., Putois, B., Martel, N., Ricordeau, F., Bastuji, H., Arnulf, I., Barateau, L., Bourgin, P., Dauvilliers, Y., Debs, R., Dodet, P., Dudoignon, B., Franco, P., Hartley, S., Lambert, I., Lecendreux, M., Leclair-Visonneau, L., Léger, D., …, & Rolland, B. (2025). Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.02.037
Vancouver
Peter-Derex L, Fort E, Putois B, Martel N, Ricordeau F, Bastuji H, et al. Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.02.037
BibTeX
@article{PeterDerex2025,
author = {Peter-Derex, Laure and Fort, Emmanuel and Putois, Benjamin and Martel, Nora and Ricordeau, François and Bastuji, Hélène and Arnulf, Isabelle and Barateau, Lucie and Bourgin, Patrice and Dauvilliers, Yves and Debs, Rachel and Dodet, Pauline and Dudoignon, Benjamin and Franco, Patricia and Hartley, Sarah and Lambert, Isabelle and Lecendreux, Michel and Leclair-Visonneau, Laurene and Léger, Damien and Lemesle-Martin, Martine and Léotard, Antoine and Leu-Semenescu, Smaranda and Limousin, Nadège and Lopez, Régis and Meslier, Nicole and Micoulaud-Franchi, Jean-Arthur and Charley-Mocana, Christelle and d'Ortho, Marie-Pia and Philip, Pierre and Ruppert, Elisabeth and de La Tullaye, Sylvie and Brigandet, Manon and Charbotel, Barbara and Mazza, Stéphanie and Rolland, Benjamin},
title = {Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study},
journal = {Sleep Medicine},
year = {2025},
doi = {10.1016/j.sleep.2025.02.037}
}
EUVIMED